Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant
Completed
- Conditions
- InflammationUveitis
- Registration Number
- NCT01060787
- Lead Sponsor
- Bausch & Lomb Incorporated
- Brief Summary
Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants
- Detailed Description
Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants on corneal endothelial cell density.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 98
Inclusion Criteria
- Had the FA intravitreal implant (0.59 or 2.1 mg) in only one eye for at least one(1) year
- Able and willing to follow instructions
- Able and willing to provide informed consent
Exclusion criteria:
- Is monocular
- Has current or relevant medical history that would interfere with their participation in this study, based on the judgment of the Investigator
- Had bilateral FA intravitreal implants
- Has a history of any severe/serious ocular pathology or medical condition that could result in the subject's inability to complete the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Corneal Endothelial Cell Density 1 Visit Bilateral specular microscopy will be performed and endothelial cell density will be recorded.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ophthalmic Partners of Boston
🇺🇸Boston, Massachusetts, United States
Ophthalmic Partners of Boston🇺🇸Boston, Massachusetts, United States